Category: Off-label Promotion

Kamp on Off-label Discussion at the CMS/FDA Summit

MIWG Asks FDA to Clarify Position Regarding Manufacturer Dissemination of New Use Information

FDA States Keywords Do Not Have To Be Reported on Form 2253s

Pitts: FDA Needs to Address Guidance on Healthcare Economic Information

Kamp in MMM: Off-label Is on the Table

Kamp To Moderate DIA Webinar on Caronia Case Implications

Federal Appeals Court Reverses Conviction of Detailer for “Off-label” Promotion

J&J Settlement Restricts Marketing Distribution of Journal Article Reprints

Appeals Court Ruling in First Amendment Tobacco Case May Lead to Supreme Court Review